Clinical Trials Directory

Trials / Recruiting

RecruitingNCT02097758

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study. Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the formula that we made before device closure in ASD patients.

Conditions

Interventions

TypeNameDescription
DEVICETranscatheter device closureClosure of atrial septal defect with device * choosing device size with 3D image and the formula * we do not use sizing balloon for choosing of the device size

Timeline

Start date
2014-03-01
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2014-03-27
Last updated
2025-02-07

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02097758. Inclusion in this directory is not an endorsement.

Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect (NCT02097758) · Clinical Trials Directory